Visceral adipose tissue plays a critical role in numerous diseases. While imaging studies often show adipose involvement in abdominal diseases, their outcomes may vary from being a mild self limited illness to one with systemic inflammation and organ failure. We therefore compared the pattern of visceral adipose injury during acute pancreatitis and acute diverticulitis to determine its role in organ failure. Acute pancreatitis-associated adipose tissue had ongoing lipolysis in the absence of adipocyte triglyceride lipase (ATGL). Pancreatic lipase injection into mouse visceral adipose tissue hydrolyzed adipose triglyceride and generated excess non-esterified fatty acids (NEFA), which caused organ failure in the absence of acute pancreatitis. Pancreatic triglyceride lipase (PNLIP) increased in adipose tissue during pancreatitis and entered adipocytes by multiple mechanisms, hydrolyzing adipose triglyceride and generating excessive NEFA. During pancreatitis, obese PNLIP knockout mice, unlike obese adipocyte-specific ATGL knockouts, had lower visceral adipose tissue lipolysis, milder inflammation, lesser organ failure, and improved survival. PNLIP knockout mice, unlike ATGL knockouts, were protected from adipocyte-induced pancreatic acinar injury without affecting NEFA signaling or acute pancreatitis induction. Therefore during pancreatitis, unlike diverticulitis, PNLIP leaked into visceral adipose tissue can cause excessive visceral adipose tissue lipolysis independent of adipocyte-autonomous ATGL, and thereby worsen organ failure.
Abstract: Visceral adipose tissue plays a critical role in numerous diseases. While imaging studies often show adipose involvement in abdominal diseases, their outcomes may vary from being a mild self limited illness to one with systemic inflammation and organ failure. We therefore compared the pattern of visceral adipose injury during acute pancreatitis and acute diverticulitis to determine its role in organ failure. Acute pancreatitis-associated adipose tissue had ongoing lipolysis in the absence of adipocyte triglyceride lipase (ATGL). Pancreatic lipase injection into mouse visceral adipose tissue hydrolyzed adipose triglyceride and generated excess non-esterified fatty acids (NEFA), which caused organ failure in the absence of acute pancreatitis. Pancreatic triglyceride lipase (PNLIP) increased in adipose tissue during pancreatitis and entered adipocytes by multiple mechanisms, hydrolyzing adipose triglyceride and generating excessive NEFA. During pancreatitis, obese PNLIP knockout mice, unlike obese adipocyte-specific ATGL knockouts, had lower visceral adipose tissue lipolysis, milder inflammation, lesser organ failure, and improved survival. PNLIP knockout mice, unlike ATGL knockouts, were protected from adipocyte-induced pancreatic acinar injury without affecting NEFA signaling or acute pancreatitis induction. Therefore during pancreatitis, unlike diverticulitis, PNLIP leaked into visceral adipose tissue can cause excessive visceral adipose tissue lipolysis independent of adipocyte-autonomous ATGL, and thereby worsen organ failure.
Introduction:
In humans, visceral adipose tissue is commonly involved in acute diseases like acute diverticulitis (1, 2), appendicitis (3, 4) , and acute pancreatitis (5) (6) (7) , but the extent of visceral adipose involvement only parallels acute pancreatitis severity (1-7). This involvement is commonly imaged as "stranding" around the inflamed organs. While both acute diverticulitis and acute pancreatitis have a sudden onset, involve visceral fat, and occur in a similar demographic, diverticulitis is often treated in the outpatient setting and rarely causes organ failure (8) , whereas acute pancreatitis requires hospitalization and has a higher risk of progression to organ failure (9) . The mechanisms underlying these differences are unknown.
Visceral fat necrosis worsens acute pancreatitis outcomes (10) (11) (12) (13) (14) in obesity. However, models mimicking acute diverticulitis (e.g., cecal ligation, puncture) have variable outcomes in obese mice (15, 16) , with some reporting that visceral adipose tissue plays a protective role (17) . A clue to this discrepancy may lay in acute non-esterified fatty acids (NEFA) elevations in acute pancreatitis (18, 19) . High NEFAs can inhibit mitochondrial complexes I and V, cause necrosis of the pancreas, renal tubular injury, acute respiratory distress syndrome (ARDS), and result in multi-system organ failure (MSOF) (13, 14, 20) . NEFA infusion can induce renal injury (21, 22) and acute respiratory distress syndrome (23, 24) . The lipase mediating this rapid and excessive NEFA generation is therefore of interest.
Lipolysis within adipocytes is normally a highly regulated process involving adipocyte triglyceride lipase (ATGL) and hormone-sensitive lipase (25) . The pancreas itself has 3 lipases: pancreatic triglyceride lipase (PNLIP); the major contributor to the pancreas' lipolytic activity (26, 27) , pancreatic lipase-related protein-2 (PNLIPRP2), and carboxyl ester lipase (CEL) (28) .
These normally digest dietary fat in the intestine. While pharmacologic lipase inhibition improves pancreatitis outcomes (13, 14) , whether adipocyte or pancreatic lipases mediate this NEFA generation is unknown. ATGL is normally the initiating and rate-limiting lipolytic enzyme in adipocytes (29) . Its adipocyte-specific deletion decreased adipocyte lipolysis and serum lipids (30) in mice. More recently, pharmacologic inhibition of ATGL has been shown to slow progression of heart failure in mice (31) . Since cardiovascular failure, shock (32, 33) , and lipotoxicity from NEFAs (14, 34) can contribute to severe acute pancreatitis, we therefore also considered whether ATGL can mediate severe acute pancreatitis.
We therefore started by comparing the pathophysiology of NEFA generation in human acute diverticulitis to acute pancreatitis, and roles of pancreatic lipases vs. ATGL in the progression to organ failure. For this we used in vitro and in vivo models of acute pancreatitis, and tested the efficacy of the specific ATGL inhibitor Atglistatin (35) , an adipocyte-specific ATGL deletion (36) , or genetic deletion of PNLIP (37) in preventing the cascade of lipolysis resulting in organ failure.
Since carboxyl ester lipase cannot hydrolyze long chain triglycerides, such as those present in visceral fat (38) (39) (40) , it was not studied.
Genetically obese mice, homozygous for mutant leptin (B6.Cg-Lep ob /J; ob/ob), have increased visceral fat (41) and unlike lean mice develop pancreatitis associated multi-system organ failure similar to human severe acute pancreatitis (10, 13, 42) . Therefore we mated ATGL or PNLIP knock outs with the leptin mutants to generate dual "ATGL floxed Cre positive (ATGL KO) ob/ob mice" or "PNLIP knockout (PNLIP KO) ob/ob" mice. These KO ob/ob mice matched the control ob/ob littermates in physical parameters and body composition. This allowed us to study the lipase(s) causing acute lipolysis of visceral adipose tissue and consequent local and systemic lipotoxic injury during acute pancreatitis. Interestingly, we note that acute visceral adipose tissue lipolysis changes pancreatitis outcomes without affecting its initiation independent of the mechanisms regulating lipolysis within adipocytes.
Results:

During human acute pancreatitis unlike diverticulitis, PNLIP accumulates in visceral adipose tissue and may hydrolyze it
Since both acute pancreatitis and acute diverticulitis have a sudden onset, involve visceral fat, and occur in a similar demographic but have very different outcomes, we first aimed to understand why visceral adipose tissue involvement during acute pancreatitis can worsen it, unlike diverticulitis. For this we compared the fat necrosis of acute pancreatitis to that of diverticulitis. An example of CT appearance of visceral adipose tissue involvement at the time of diagnosing acute diverticulitis or acute pancreatitis is shown in Figure 1 A-D. The day from disease onset is mentioned below the images. While both diseases had visceral adipose tissue involvement around the colon (C) and pancreas (P) respectively (yellow outline Fig. 1 A-D), this increased in size over time during acute pancreatitis ( Fig. 1 B-D) . Patients with acute pancreatitis had a higher prevalence of organ failure than those with acute diverticulitis (5/8 vs. 0/8, p=0.03) despite being younger (Table in Fig. S1 ). The interval from the onset of disease to the time of surgery averaged 2 months in both cases (Fig. S1 ). We then analyzed the visceral fat samples removed at the time of surgery for these diseases. Uninvolved fat was not tested.
Histologically, acute diverticulitis showed intense adipose tissue acute inflammation with myeloperoxidase positive infiltrate ( Fig. 1E ). However, the adipocytes appeared normal ( Fig. 1F) and stained negative for calcium (no black staining in von-Kossa; Fig. 1 G) and PNLIP ( Fig. 1H ).
On a 0-3 scale, a blinded pathologist scored these 0 and 0-1 respectively in diverticulitis (Table   in Fig. 1I ). Fat necrosis during acute pancreatitis bordered pancreatic necrosis and, appeared chalky pink on H&E staining as shown previously ( Fig. 1J) (14, 43) . The necrosed adipocytes, unlike normal ones (green outline), stained positive for calcium (black stain, black arrows in Fig.   1K , scored as 3/3), consistent with saponified NEFA in the fat necrosis (14, 43) . Serial sections scored 3/3 for PNLIP (brown arrows in brown areas, ( Fig. 1L ), in von-Kossa positive areas, unlike the fat in diverticulitis. Thus there was a histologic evidence of PNLIP leakage from the pancreatitis into fat necrosis ( Fig. 1L ) unlike during diverticulitis ( Fig. 1F-H ). This has been noted previously in human (44) (45) (46) and experimental pancreatitis (47) (48) (49) .
On thin layer chromatography, the involved fat in acute diverticulitis remained predominantly triglyceride ( Fig. 1M ), but was hydrolyzed to NEFA in acute pancreatitis, with NEFA concentrations of 3.5±2.9mM. Similar to previous reports (14) , oleic acid (C18:1) was the principal NEFA, comprising 38±10%. The fat in acute pancreatitis contained higher activity of pancreatic lipase, amylase, and trypsin compared diverticulitis ( Fig. 1N-P) . Interestingly, on western blotting, there was no detectable ATGL or perilipin-1 protein in the fat necrosis, while these proteins were present in diverticulitis ( Fig. 1Q ). Adiponectin was used as a marker for adipocytes and was present in both pancreatitis and diverticulitis. This result suggested that acute pancreatitis caused leakage of pancreatic hydrolases into the visceral adipose tissue, which degraded proteins and triglycerides normally present in visceral adipose tissue. Such leakage has previously been shown in human pancreatitis (44) (45) (46) and experimental pancreatitis (47) (48) (49) . Overall, these findings supported the need to verify that visceral adipose tissue could undergo lipolysis independent of ATGL, and to understand the mechanisms underlying this lipolysis which results in organ failure.
Pancreatic lipase hydrolyzes visceral adipose tissue causing fat necrosis, organ failure, and worsening inflammation
We went on to investigate whether a non-adipocyte lipase can cause visceral adipose tissue necrosis and organ failure. For this we first injected pancreatic lipase extracted from pigs (50) into the fat pads of ob/ob mice alone or along with the lipase inhibitor orlistat. Lipase injection dramatically reduced survival over 24 hours ( Fig. 2A ). Grossly, there was fat necrosis seen as round white deposits all over the visceral fat of the lipase treated mice, which was prevented by orlistat ( Fig. 2B ). The lipase injection also increased fat pad pancreatic lipase activity (Fig. 2C ), and hydrolyzed adipocyte triglyceride into to NEFA (Fig. 2D ). This lipolysis resulted in a 66±44fold increase in various long chain NEFAs in visceral fat, with oleic acid (C18:1) being the main one (84±44 fold, Fig. 2E ). All these changes were prevented by orlistat. This lipolysis also resulted in a large increase in serum cytokines IL6, MCP-1 and TNF- (# Fig. 2F -H) and blood urea nitrogen elevation signifying renal injury ( Fig. 2I ), which were measured at the time of euthanasia. These increases were prevented or reduced by orlistat (* Fig. 2F -I). Additionally, lipolysis caused a large drop in rectal temperature and carotid pulse distension implying hypothermia and shock ( Fig. 2J, K) , which are a part of the severe systemic inflammatory response syndrome. These parameters, which were measured 12-16 hours after injection and before euthanasia was initiated, were also normalized by lipase inhibition.
Since NEFA generation immediately follows lipolysis, we went on to test whether NEFA alone could result in an inflammatory response and organ failure. Noting oleic acid (OA; C18:1) to comprise a high proportion of NEFA in both human pancreatic necrosis collections and fat necrosis in mice, we studied the effect of administering OA to lean (CD-1) mice. OA (0.3% body weight), when given intraperitoneally to simulate visceral fat necrosis, increased serum OA concentrations (311±103M vs. 132±53M in controls p<0.003, Fig. 3A ). OA-treated mice became progressively less active, requiring euthanasia at 48±13 hours. At this time there was a large increase noted in serum cytokines IL-6, MCP-1 and TNF- (shown as * in Fig. 3B -D) and BUN ( Fig. 3E ) in the OA-treated group versus controls. Prior to euthanasia the OA-treated mice were in shock and hypothermic ( Fig. 3F , G).OA treatment increased TUNEL positive cells in the lung from 0.2±0.1% to 2.7±1.4%, p<0.001 ( Fig. 3H ) similar to acute respiratory distress syndrome in rodents (24) and humans (51) .
To test the clinical relevance of our findings with OA in a blinded fashion, OA concentrations were measured in a separate cohort of patients at the University of Pittsburgh detailed in table 1. Some of these had severe acute pancreatitis, which is characterized by the presence of organ failure for more than 48 hours (52) . OA levels in severe acute pancreatitis patients (n=15) were significantly higher versus normal controls (n=15) who were demographically similar ( Fig.   3I ). OA levels in patients were similar to the levels noted in OA treated and control CD-1 mice ( Fig. 3A ).
Cumulatively these showed that during acute pancreatitis, unlike diverticulitis, pancreatic lipase can hydrolyze visceral adipose tissue, generate NEFA, which cause multi-system organ failure independent of intra-pancreatic phenomena. We further validated these findings using the standard caerulein acute pancreatitis model in lean and obese (ob/ob) mice. In ob/ob mice, fat necrosis was first noted at 12 hours near the pancreas ( Fig. S2A , red rectangles). This increased in amount and distance from the pancreas over time and appeared similar to what was noted after lipase injection ( Fig. 2B ). Increased PNLIP and PNLIPRP2 were noted in the fat by 6h (Fig. S2B ), and reduced amount of ATGL, perilipin-1 ( Fig. S2K ) were noted after 12h, which correlated with an increase in pancreatic enzymes like trypsin and amylase in the fat necrosis ( Figure S2L ). Trypsin has been previously shown to hydrolyze ATGL (53) . Circulating amylase and lipase activity, which are markers of ongoing acute pancreatitis, were similarly elevated during acute pancreatitis ( To understand how pancreatic lipases enter adipocytes, we exposed 3T3-LI cells to PNLIPmcherry in the presence of phospholipase A2, several isoforms of which are involved in acute pancreatitis (54) (55) (56) . This allowed the entry of PNLIP into the adipocytes (Fig. S4A ). Similarly, PNLIPRP2, which has a phospholipase like activity (27) , allowed the entry of a live/dead marker into these cells (Fig. S4B ). The injurious role of PNLIPRP2 (unlike its inactive S148G mutant or PNLIP) was supported by its expression in HEK293 cells causing a significant increase in LDH leakage vs. PNLIP( Fig. S4C ). Lastly, exposure of 3T3-L1 adipocytes to linoleic acid previously shown to be present at ≈2 mM in acute pancreatitis collections also injured adipocytes leading to entry of PNLIP into the cells (Fig. S4D ). Thus, pancreatic enzymes including lipases which may leak from a disrupted duct (57, 58) , or basolaterally during human (44) (45) (46) and experimental pancreatitis (47) (48) (49) can enter the surrounding visceral adipocytes in multiple ways and cause organ failure. We, therefore, went on to identify the relative contribution of pancreatic lipases versus ATGL to acute pancreatitis-associated fat necrosis, and consequent pancreatic acinar necrosis, the source of pancreatic lipase leak.
Pharmacological inhibition or genetic deletion of ATGL is not sufficient to prevent adipocyte-induced lipotoxic acinar injury
As previously shown, NEFA injure pancreatic acini (14, 59) and other cell types such as the kidney cell line HEK293 (40) . To initially identify the lipase(s) mediating the cell injury resulting from fat necrosis, we used a previously described method (14, 43) . Using this method, we cocultured wild type adipocytes and pancreatic acini alone or in the presence of Atglistatin (50M); the ATGL-specific inhibitor (35) which does not inhibit pancreatic lipases or the generic lipase inhibitor orlistat (50M; Fig. 4A -D). As previously shown (14, 43) during co-culture, these were separated by a 3M pore size mesh (Fig. 4A ). This system therefore allows the macromolecules released from one cell type to interact with the other cell type, thus simulating the leak of pancreatic lipases into adipose tissue noted previously during human (44) (45) (46) and mouse acute pancreatitis (14, 43) . This model is relevant to the current study (Figs. 1, 2, S2-S4) since it allows the leaked pancreatic enzymes access to adipocytes and their triglyceride in the lower chamber ( Fig. 4A ), and conversely allows glycerol and NEFAs from adipocytes access to acini in the upper chamber, where these molecules can be measured. Injury to acini (or its prevention thereby) can thus be measured by staining the acini in the upper chamber with a live/dead marker such as trypan blue or propidium iodide, as shown previously (14, 43) .
We initially noted the generic lipase inhibitor orlistat inhibited pancreatic lipase activity, reduced the lipolytic generation of glycerol and consequent lipotoxic necrosis of acini (14) , as measured by their uptake of propidium iodide and trypan blue ( These data suggest that PNLIP, rather than ATGL, mediates the unregulated lipolysis of adipocyte triglyceride, its subsequent NEFA release, and lipotoxic cell injury (14, 43) . These findings along with 1) in vivo evidence that visceral fat necrosis is mediated by pancreatic lipases (Fig. 2) , and contains PNLIP, PNLIPRP2 but less ATGL ( 
PNLIP (but not PNLIPRP2) mediates lipotoxic NEFA generation without affecting lipotoxic
NEFA signaling
We first chose to identify the pancreatic lipase to be targeted. Pancreatic necrosis collections are enriched in NEFA with 16 or more carbons (14, 34, 60) such as OA and linoleic acid. Triglycerides esterified to these long-chain fatty acids serve as poor substrates for the bile salt-dependent carboxyl ester lipase (CEL) (38) (39) (40) . Thus we focused our attention on PNLIP (black/white/grey) and PNLIPRP2 (burgundy/ dirty yellow) by comparing their relative contributions in lipolytic release of lipotoxic mediators relevant to acute pancreatitis ( Fig. 5 ). At equimolar amounts, both enzymes from mice, similar to the human forms (40) , were effective in hydrolyzing the triglyceride of linoleic acids (LA), i.e., glyceryl trilinoleate (GTL; Fig. 5A PNLIP KO acini to have a blunted response to GTL, while responding similarly to LA. These protective effects were not due to a generic decrease in exocrine enzyme release by the cells since only the lipase activity, but not amylase activity, was reduced in the medium of the PNLIP KO acini resulting in a reduced NEFA generation ( Fig. 5J-L) . Thus, the protection in PNLIP KO acini is by reducing triglyceride lipolysis and not by interference with the lipotoxic mechanisms of NEFA. We next sought to compare the role of PNLIP versus ATGL in severe acute pancreatitisassociated fat necrosis using obese ATGL KO or obese PNLIP KO mice.
Deficiency of PNLIP, but not ATGL, prevents visceral adipose tissue lipolysis during severe acute pancreatitis and improves outcomes
To confirm homogeneity between different animal groups, we first compared the body weight, adipose weights, and fatty acid composition of the gonadal fat pads (that get necrosed) of ob/ob ATGL KO and ob/ob PNLIP KO mice and their ob/ob littermates ( Fig. 6A, B) . These parameters were similar in all three groups. Similarly, the increase in pancreatic edema (measured as % water weight/tissue wet weight) and circulating amylase 24h after induction of pancreatitis were similar in all three groups (Fig. 6C, D) . These results indicate that all groups had a similar susceptibility to acute pancreatitis. The PNLIP KO group, however, had lower circulating pancreatic lipase levels at baseline and throughout the course of acute pancreatitis supported by previous studies in humans (14, 43) . Obese PNLIP KO mice however had dramatically reduced fat necrosis, PFAN, and total necrosis ( ATGL KO mice with acute pancreatitis (Figs. 7I-L, S10). This was unlike in the ob/ob PNLIP KO mice, whose parameters for organ failure, even at the end of the study, were no different from control mice without acute pancreatitis and which had a 100% survival ( Fig. 7M ).
We went on to test whether the role of PNLIP was relevant to a mechanistically different acute pancreatitis model using IL12, 18 ( Fig. S11 ), which are cytokines increased in human severe acute pancreatitis (63, 64) . All ob/ob mice with acute pancreatitis were moribund by day protected over the 5-day course of the study and had near normal circulating amylase and lipase ( Fig. S11B , C) at the time of elective euthanasia. On necropsy, these mice had grossly reduced visceral fat necrosis and no increase in measureable lipase activity in the fat pads ( Fig.   11D , G). This was verified microscopically and was associated with reduced pancreatic necrosis ( Fig. S11E, F) , even though acinar-ductal metaplasia (ADM) was increased. The severe visceral adipose tissue necrosis was associated with a large increase in circulating NEFAs, including C18:1, and a severe inflammatory response, both of which were reduced in the PNLIP KO mice 
Deficiency of PNLIP activity does not affect the signaling that leads to the initiation of acute pancreatitis
Since acute pancreatitis is initiated in pancreatic acinar cells (65), we went on to check whether PNLIP affected the induction of acute pancreatitis by comparing the signaling induced by caerulein in the acini of WT and PNLIP KO mice (grey, Fig 8A-C) . Caerulein acts via the cholecystokinin receptor and at high doses (>10 -9 M) relevant to acute pancreatitis, it causes a sustained increase in cytosolic calcium (66, 67) . The two types of acini showed no difference in the caerulein induced increase in cytosolic calcium, pattern of exocrine enzyme amylase secretion, or the generation on trypsin ( Fig. 8A-C) . Thus the protection seen in the ob/ob PNLIP KO mice during caerulein acute pancreatitis is not due to interference with the caerulein signaling leading to acute pancreatitis or the function of cells in which acute pancreatitis is initiated. We further went on to study the validity of this in vivo by comparing lean wild type and lean PNLIP KO mice during a short 10-hour course of caerulein acute pancreatitis. Here, the PNLIP KO mice were not protected from the increase in circulating amylase (Fig. 8D) , pancreatic edema (measured as % water weight/wet weight; Fig. 8E ), and acinar necrosis (arrows showing diffuse pink cytoplasm and loss of cell outlines Fig. 8F ), despite preventing the increase in circulating lipase compared to wild type mice (Fig. 8G) . Consistent with the short course of acute pancreatitis and relative paucity of visceral adipose tissue in lean mice, neither strain had an increase in serum NEFA, blood urea nitrogen, or loss of thermoregulation with acute pancreatitis (Fig. S12A-C) . Similarly, during IL12, 18 pancreatitis, PNLIP KO mice had a similar increase in serum amylase at 24 hours and pancreatic edema versus the wild type mice ( Fig. 8H, I) . However, the increase in circulating lipase was completely prevented in the PNLIP KO mice (Fig. 8J ). Again, serum BUN and rectal temperature were similar (Fig. S12D, E) between WT and PNLIP KO mice. Based on these findings, we can conclude that the protection noted in the PNLIP KO mice is not due to interference with the initiation of acute pancreatitis.
Rather these mice are protected from the lipotoxicity that ensues from excessive visceral adipose tissue lipolysis mediated by the leakage of PNLIP into the visceral adipose tissue ( Fig.   9 ), which causes systemic inflammation and organ failure.
Discussion:
In this study we note that acute, excessive visceral adipose tissue lipolysis by pancreatic lipase can cause systemic injury, and then identify PNLIP as the principal lipase mediating this during acute pancreatitis. This explains the higher prevalence of organ failure in acute pancreatitis compared to diverticulitis, despite both diseases being acute, occurring in a similar demographic, and having visceral fat involvement. Diverticulitis however does not have ongoing visceral fat lipolysis despite the radiographically apparent visceral fat involvement and intense inflammation seen histologically. As summarized in Figure 9 , these studies show that during acute pancreatitis, PNLIP leaks from the injured pancreas into the surrounding adipocytes with its entry facilitated by multiple mechanisms (Fig. S4 ). PNLIP mediated lipolysis results in the release of large quantities of NEFA like oleic acid, which cause inflammation and elevated cytokines, thus worsening lung, kidney injury, and shock culminating in multi-system organ failure and reduced survival. We additionally note that PNLIP has no role in the mechanisms leading to the initiation of acute pancreatitis or the signaling mediated by the lipotoxic NEFAs such as linoleic acid (LA) generated by lipolysis. Remarkably, this cascade of events leading to organ failure is independent of the principal adipocyte lipase, ATGL, which is present in diverticulitis but not pancreatitis.
Previous studies have shown that lipotoxic NEFA enriched in necrotic pancreatic fluid collections can cause mitochondrial damage, noted as swelling and disorganization of their ultrastructure, along with inhibiting complexes I and V (14) . The systemic injury we note as TUNEL positive cells in the lungs and kidneys has previously been shown using oleic acid (21, 23, 24) and linoleic acid (40, 68) , and during human ARDS (51) . Here we identify PNLIP as the principal lipase mediating this uncontrolled generation of NEFA from visceral fat lipolysis.
While visceral adipose stranding is radiologically seen around the affected tissue during acute pancreatitis, appendicitis, acute diverticulitis (69), epiploic appendicitis, and omental infarction(1, 2), its role in predicting severity has only been noted in acute pancreatitis (5) (6) (7) .
This study shows PNLIP mediates this severity by hydrolyzing visceral fat during acute pancreatitis but not acute diverticulitis, despite the latter having intense inflammation (Fig. 1E ). This pathophysiology is evidenced by 1) triglycerides being the predominant lipid class in the fat of acute diverticulitis, but NEFA being the one in acute pancreatitis (Fig. 1M) ; 2) Histological evidence of PNLIP in fat necrosis (Fig. 1L) ; 3) Biochemical evidence of PNLIP in fat necrosis cytokines, serum NEFA increase, and organ failure ( Fig. 7) , supports these outcomes to be independent of ATGL. This is further supported by the co-culture system in which we note adipocyte induced acinar injury to be dependent on lipolysis (since it is inhibited by orlistat, and in PNLIP KO mice acini), which is unaffected by using atiglistatin or ATGL KO adipocytes ( Fig   4) . Therefore, while ATGL does play a major role in regulated lipolysis of adipocyte triglyceride such as due to isoproterenol (Fig. S5 ), its role in acute pancreatitis associated visceral adipose tissue necrosis and organ failure is unlikely.
Among the pancreatic lipases, we note that PNLIP, which contributes to 80-90% of the pancreas' lipolytic activity, has a bigger role than PNLIPRP2 ( Fig. 5A-E) in lipotoxic cell injury due to the hydrolysis of triglyceride. This relative abundance of PNLIP can explain the protective phenotype we observe in vitro (Fig. 5F -I) and in vivo (Figs. 6, 7 , S11). The role of another lipase is possible, noting the minimal fat necrosis in the PNLIP KO mice during IL12, 18 acute pancreatitis (Fig. S11D) , and partial protection from GTL induced injury in acini from the PNLIP KO mice (Fig. 5F, G) . However, PNLIPRP2's clinical relevance is likely to be low since about 50% of Europeans are heterozygous and 20% homozygous for a common PNLIPRP2 truncation variant which results in nonsense-mediated decay, thus inhibiting expression of PNLIPRP2 on the mRNA level (70) . Since carboxyl ester lipase cannot effectively hydrolyze triglycerides with fatty acids of >16 carbon chains (38, 39) and requires bile acid concentrations much higher than in pancreatic necrosis collections (40) , it is unlikely to play a major role in fat necrosis.
The protection afforded in the PNLIP KO acini and in mice is unique since PNLIP does not interfere with the mechanisms initiating pancreatitis such as the caerulein induced increase in cytosolic calcium or trypsinogen activation (Fig. 8A, C) . This supports the hypothesis that inhibiting or neutralizing a disease modifier (in this case PNLIP) can change disease outcomes even after disease initiation. This finding also allows PNLIP neutralization or inhibition to be a therapeutic strategy, since fat necrosis becomes visible after 12 hours of pancreatitis ( Fig. S2A) and precedes organ failure (Fig. S2I ).
The data from the randomly accrued series of human samples, while blinded are limited by the study design being observational, small in size, and us not controlling for the use of intravenous lipids. Despite these limitations, the differences between diverticulitis and pancreatitis outcomes are significant. Future studies to validate these may be helpful. In the mouse studies, the small group size (3-7) for each sex, may have limited our ability to detect such differences. We also do not focus on the other factors that may influence PNLIP action.
For example, we do not detail amount or type of phospholipase(s) or the dose response and time course of PNLIPRP2 that allow PNLIP entry into adipocytes (Fig. S4) . Similarly, we did not study the role of co-lipase, which is PNLIP's co-factor that increases its activity 3-5 fold (26) .
Additionally, while adiponectin was detectable, ATGL or perilipin-1 underwent proteolysis. This is potentially explained by progressive accumulation of trypsin during fat necrosis in murine acute pancreatitis (Fig. S2L) , and the detectable trypsin activity (Fig. 1P ) in human acute pancreatitis-associated visceral adipose tissue necrosis. Overall, the genetic and pharmacologic evidence provided make PNLIP and not ATGL the likely mediator of the acute visceral adipose tissue lipolysis which worsens acute pancreatitis.
In summary, we note PNLIP, but not ATGL to be the principal mediator of excessive and unregulated visceral adipose tissue lipolysis during acute pancreatitis. This phenomenon does not take place in diverticulitis and explains why the visceral adipose tissue involvement in acute pancreatitis parallels disease severity. This also explains the prognostic role of visceral adipose tissue involvement in acute pancreatitis but not diverticulitis and perhaps other acute abdominal diseases. Visceral adipose tissue lipolysis by PNLIP generates a large amount of NEFA, which mediate severity of acute pancreatitis independent of its initiation, potentially making PNLIP a pharmacologic target to improve outcomes after disease onset.
Methods:
Human samples: All human studies were approved by the institutional review board of the Mayo Clinic (16-000973), University of Pittsburgh (Pro00000496) or Committee for Oversight of Research Involving the Dead University of Pittsburgh. We compared acute diverticulitis to acute pancreatitis for the following reasons: A) both are acute, B) both occur in the same demographic, C) both have radiographic (e.g., CT scans) and pathologic involvement of visceral fat, yet 4) their outcomes are very different, with a high prevalence of organ failure in pancreatitis versus diverticulitis. We wanted to understand the mechanism of higher organ failure in pancreatitis. All biochemical studies (October 2015 till May 2017) were done as part of a prospectively done observational study using consecutively procured patient waste residual samples remaining after drainage or after testing and processing had been completed on the tissue (in the pathology or microbiology departments) for medically indicated procedures independent of this research, and the residual was ready to be discarded. For example, the samples used for the current studies were residual material from pancreatic necrosis drained as per the revised Atlanta criteria (52) via surgical, endoscopic, or percutaneous debridement. The debridement procedures were clinically indicated and we had no control over what surgery the patient had, or which sample was designated as waste. These specimens were de-identified by an honest broker and the analysts were blinded to the patients' clinical data till after all biochemical analyses and histological analyses were complete. Histology was done on formalin fixed paraffin embedded samples of surgically resected tissue (diverticulitis) of the same patients whose samples were analyzed biochemically (n=8), or acute pancreatitis sections (n=8) retrieved from an autopsy database search described in a previous study (14) while excluding autolysis and post mortem change as described therein (14) . Transportation from the clinical source to the research lab was within 30 minutes of being released. These were kept on ice, aliquoted, and then frozen at -80C or fixed in formalin. Once 8 samples from each group had been procured and analyzed, the clinical data were mined. Organ failure was defined by a modified Marshall score of ≥ 2 more for the respiratory, renal or cardiovascular system, which is used to stratify patients in by the revised Atlanta criteria (52) .
University of Pittsburgh severe acute pancreatitis patient cohort: This cohort was used to compare the serum levels of oleic acid in humans with severe acute pancreatitis to the mice with organ failure in a blinded and independent fashion. Samples were from the Pancreatitisassociated Risk of Organ Failure (PROOF) study. PROOF is an observational study at UPMC of subjects with AP early in their hospitalization, which recently completed enrollment. The PROOF protocol has been approved by the Institutional Review Board (IRB) of the University of Pittsburgh (Pro00000496) and submitted to the US National Library of Medicine (ClinicalTrials.gov Identifier: NCT03075605). The clinical protocol and cohort characteristics have been previously described (71) . For this analysis, serum samples of 15 randomly chosen patients with severe AP patients and demographically matched controls without pancreatic diseases enrolled in PROOF between 2012 and 2015 were collected at enrollment and subsequent days when available. Oleic acid was extracted and quantitated using gas chromatography separation with flame ionization detection as previously described (72) . Data on demographics, etiology, and clinical course were prospectively collected. Severity was defined by the Revised Atlanta Classification (52) . 14 respectively were used. PNLIP KO and ATGL KO mice were serially mated to leptin heterozygous (wt/ob) mice for at least 2 generations with selection of the desired alleles to generate experimental mice in the following groups: 1) ob/ob PNLIP KO, which were homozygous for both leptin (ob/ob) and PNLIP KO alleles congenic on C57BL/6J, and 2) ob/ob ATGL KO , which were homozygous for leptin and ATGL flox alleles and heterozygous for the Cre allele. Although the latter were mixed C57BL/6J (>75%) and C57BL/6Ntac (<25%), confirmatory experiments revealed that these mice had loss of ATGL and its lipolytic action ( Fig. 7C; Fig. S5) and were phenotypically similar to the other strains in the study (Fig. 6A, B) . Obese littermates homozygous for leptin (ob/ob) with WT for PNLIP or ATGL were used as controls. Mice with a genetic deletion of PNLIPRP2 generated as described previously (74) were used to study its role in comparison to PNLIP. The genotype of all mice was confirmed after agarose gel electrophoresis of polymerase chain reaction amplification of tail DNA following Jackson Laboratory genotyping protocols and using AccuStart II PCR Genotyping Kit (Quantabio).
PNLIP KO mice were identified using the following primers: wild type forward -CAA ACA   GCT AAT TAC TTC AGA TGC, KO forward -GCT ATC AGG ACA TAG CGT TGG, and   common reverse -GGA CAG TGT CTT GCT GGT All animal protocols used in this study were approved by the Institutional Animal Care and Use Committee at Mayo Clinic. Males and females were used in this study.
Body weight and body composition assessment: Mouse weight, body fat and lean mass
were analyzed by quantitative nuclear magnetic resonance (NMR) as previously (13) just before the experiments. Rest of the methods are described in the supplementary section.
Statistics: Independent variables for in vivo and in vitro studies are shown as bar graphs reported as mean ± SEM. line graphs were used for continuous variables. Significance levels were evaluated at p<0.05. Data for multiple groups were compared by 1-way ANOVA versus controls and values significantly different from controls were shown as (*) unless otherwise mentioned specifically in the legend (e.g., Fig. 2 ). When comparing 2 groups a t-test or Mann-Whitney test was used depending on the normality of distribution. Graphing was done using In the upper part of the left iamge is shown a perforated diverticulum in the colon with spillage of contents into the visceral adipose tissue. In the lower panel is the zoomed in view showing the consequent intense local inflammation in the peri-colonic visceral adipose tissue. However the triglyceride (red E) within adipocytes is not degraded and the ATGL (green dots) remains intact. This is associated with a low prevalence of organ failure during diverticulitis. On the right, is shown the involvement of visceral adipose tissue in pancreatitis, with the zoomed in view at the bottom showing the leakage of pancreatic enzymes (dark blue) including PNLIP (light blue) into the visceral adipose tissue. The resulting adipocyte injury results in entry of PNLIP into the injured adipocytes resulting in hydrolysis of adipocyte triglyceride into NEFA (red wavy lines), and degradation of ATGL seen as loss of green dots. The entry of NEFA into the systemic circulation causes elevated cytokines, organ failure including acute respiratory distress syndrome (ARDS), acute renal failure (ARF), and cardiovascular failure (CVF).
Parameter
Control patients (15) Severe AP patients ( 
